placeholder image
R. M. Cuddihy All authors
About
Publications While At HealthPartners
selected publications
Journal Article
  • Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience. 
    Diabetologia. 2012
  • Comparison of a novel insulin bolus-patch with pen/syringe injection to deliver mealtime insulin for efficacy, preference, and quality of life in adults with diabetes: a randomized, crossover, multicenter study. 
    Diabetes Technology & Therapeutics. 2011
  • Effect of intensive glycemic lowering on health-related quality of life in type 2 diabetes: ACCORD trial. 
    Diabetes care. 2011
  • Improving blood pressure control in individuals with diabetes: a quality improvement collaborative. 
    Joint Commission journal on quality and patient safety. 2011
  • Performance evaluation and labeling comprehension of a new blood glucose monitoring system with integrated information management. 
    Journal of Diabetes Science and Technology. 2011
  • Continuous glucose monitoring reveals different glycemic responses of moderate- vs high-carbohydrate lunch meals in people with type 2 diabetes. 
    Journal of the American Dietetic Association. 2010
  • Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. 
    Lancet (London, England). 2010
  • Effects of exenatide combined with lifestyle modification in patients with type 2 diabetes. 
    American Journal of Medicine. 2010
  • Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial. 
    Lancet (London, England). 2010
  • The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. 
    BMJ (Clinical research ed.). 2010
  • A comparison between simplified and intensive dose-titration algorithms using AIR inhaled insulin for insulin-naive patients with type 2 diabetes in a randomized noninferiority trial. 
    Diabetes Technology & Therapeutics. 2009
  • Diurnal glucose patterns of exenatide once weekly: a 1-year study using continuous glucose monitoring with ambulatory glucose profile analysis. 
    Endocrine Practice. 2009
  • Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). 
    Lancet (London, England). 2009
  • Self-Monitoring of Blood Glucose (SMBG) Applications and Beyond, 2nd Annual Symposium, May 7-10, 2009, Berlin, Germany. 
    Diabetes Technology & Therapeutics. 2009
  • Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. 
    Diabetes Technology & Therapeutics. 2008
    • Review
  • Considerations for diabetes: treatment with insulin pen devices [review]. 
    American Journal of Therapeutics. 2013
  • In support of an early polypharmacy approach to the treatment of type 2 diabetes [review]. 
    Diabetes, Obesity & Metabolism. 2010
  • Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use [review]. 
    European Journal of Internal Medicine. 2009
  • Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use [review]. 
    American Journal of Medicine. 2009
    • Contact
    full name
  • R. M. Cuddihy
    • Quick Info
     
    Collaboration